CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling.
Zihao WeiYing WangJiakuan PengHonglin LiJunjie GuNing JiTaiwei LiXi-Kun ZhouXin ZengJing LiQianming ChenPublished in: Cell death discovery (2022)
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world, the 5-year survival rate of patients with HNSCC is still about 50% due to frequent metastasis and recurrence. Circular RNAs (circRNAs) have been characterized as key regulators of gene expression in numerous malignancies. However, the role of circRNA in HNSCC metastasis remains largely unknown. Here, we demonstrated that the circRFWD3 was significantly upregulated in HNSCC tissues and cell lines by circRNA microarray analysis and qPCR. Notably, high expression of circRFWD3 is related to highly aggressive HNSCC cell lines and lymph node metastasis in HNSCC patients. After that, Sanger sequencing, RNase R, and actinomycin D assay were performed to verify the ring structure of circRFWD3. Then functional experiments found it could promote the metastasis of HNSCC cells both in vitro and in vivo. Mechanistically, a dual-luciferase reporter assay, FISH, RIP, RNA pull-down, RNA-seq, and western blot experiments were employed and found that circRFWD3 served as a miRNAs sponge for miR-27a/27b, leading to the upregulation of PPARγ, and then promoted HNSCC metastasis via NF-κB/MMP13 pathway. Finally, ISH and IHC were carried out to determine the expression levels and clinical significances of circRFWD3 and PPARγ in clinical cohorts of HNSCC. According to the analysis results from two independent HNSCC cohorts, upregulated expression of circRFWD3 and PPARγ were positively associated with worse survival in patients with HNSCC. Overall, our results uncover that circRFWD3 acts a critical role in promoting the aggressiveness of HNSCC cells and is a prognostic marker for the disease, indicating that circRFWD3 may act as a potential therapeutic target in HNSCC.
Keyphrases
- pi k akt
- cell cycle arrest
- cell proliferation
- gene expression
- poor prognosis
- lymph node metastasis
- rna seq
- single cell
- squamous cell carcinoma
- papillary thyroid
- induced apoptosis
- type diabetes
- insulin resistance
- ejection fraction
- metabolic syndrome
- risk assessment
- immune response
- dna methylation
- newly diagnosed
- skeletal muscle
- end stage renal disease
- young adults
- crispr cas
- toll like receptor
- prognostic factors
- lps induced